BR9907911A - Derivado de ácido carboxìlico, uso do mesmo, combinação, e, preparação de droga para administração oral, parenteral e intra-parenteral - Google Patents

Derivado de ácido carboxìlico, uso do mesmo, combinação, e, preparação de droga para administração oral, parenteral e intra-parenteral

Info

Publication number
BR9907911A
BR9907911A BR9907911-9A BR9907911A BR9907911A BR 9907911 A BR9907911 A BR 9907911A BR 9907911 A BR9907911 A BR 9907911A BR 9907911 A BR9907911 A BR 9907911A
Authority
BR
Brazil
Prior art keywords
alkyl
carboxylic acid
naphthyl
phenyl
hydrogen
Prior art date
Application number
BR9907911-9A
Other languages
English (en)
Inventor
Wilhelm Amberg
Rolf Jansen
Andreas Kling
Dagmar Klinge
Hartmut Riechers
Stefan Hergenr Der
Manfred Raschack
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9907911A publication Critical patent/BR9907911A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADO DE áCIDO CARBOXìLICO, USO DO MESMO, COMBINAçãO, E, PREPARAçãO DE DROGA PARA ADMINISTRAçãO ORAL, PARENTERAL E INTRA-PARENTERAL" A invenção refere-se a derivados de ácido carboxílico de fórmula (I) em que os substituintes têm os seguintes significados; R¹ = tetrazol ou um grupo (1): R = um radical OR^ 7^ (2), (3): um heteroaromático de 5 membros ligado por um átomo de nitrogênio tais como pirrolila, pirazolila, imidazolila e trizolila; R², R³ = hidrogênio, hidroxi, NH~ 2~, NH(C~ 1~-C~ 4~-alquila), N(C~ 1~-C~ 4~-alquila)~ 2,~ halogênio, C~ 1~-C~ 4~-alquila, C~ 2~-C~ 4~-alquenila, C~ 2~-C~ 4~-alquinila, C~ 1~-C~ 4~-hidroxialquila, C~ 1~-C~ 4~-alcoxi, C~ 1~-C~ 4~-halogenoalquila, C~ 1~-C~ 4~-alcoxi, C~ 1~-C~ 4~-halogenoalcoxi, ou C~ 1~-C~ 4~-alquiltio; X = halogênio, C~ 1~-C~ 4~-halogenoalquila, hidroxi, R^ 4^ e R^ 5^ = fenila ou naftila, C~ 3~-C~ 7~-cicloalquila, fenila ou naftila que são ligados na posição orto por uma ligação direta, um grupo metileno, etileno, ou etenileno, um átomo de oxigênio, ou enxofre ou um grupo SO~ 2~-NH ou N-alquila ou um heteroaromático de 5-membros ou 6-membros; R^ 6^ = hidrogênio, fenila ou naftila, um heteroaromático de cinco ou seis membros; C~ 1~-C~ 8~alquila, C~ 3~-C~ 6~-alquenila, C~ 3~-C~ 6~-alquinila ou C~ 3~-C~ 8~-cicloalquila, pelo qual os citados radicais podem ser substituídos uma vez ou muitas vezes, com a condição de que R^ 6^ só pode significar hidrogênio se Z não representar uma ligação simples; Z = enxofre, oxigênio ou uma ligação simples, além de sais fisiologicamente compatíveis e as formas enanciomérica-pura e diastereomérica-pura. Os novos compostos são adequados para combater as doenças, especialmente como antagonistas de endotelina.
BR9907911-9A 1998-02-17 1999-02-05 Derivado de ácido carboxìlico, uso do mesmo, combinação, e, preparação de droga para administração oral, parenteral e intra-parenteral BR9907911A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19806438A DE19806438A1 (de) 1998-02-17 1998-02-17 Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung
PCT/EP1999/000776 WO1999042453A1 (de) 1998-02-17 1999-02-05 5-substituierte pyrimidin-2-yloxy-carbonsäurederivate, deren herstellung und deren verwendung als endothelin-antagonisten

Publications (1)

Publication Number Publication Date
BR9907911A true BR9907911A (pt) 2000-10-24

Family

ID=7857948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907911-9A BR9907911A (pt) 1998-02-17 1999-02-05 Derivado de ácido carboxìlico, uso do mesmo, combinação, e, preparação de droga para administração oral, parenteral e intra-parenteral

Country Status (20)

Country Link
EP (1) EP1066268A1 (pt)
JP (1) JP2002503726A (pt)
KR (1) KR20010086247A (pt)
CN (1) CN1291190A (pt)
AR (1) AR014960A1 (pt)
AU (1) AU3027199A (pt)
BG (1) BG104577A (pt)
BR (1) BR9907911A (pt)
CA (1) CA2321182A1 (pt)
DE (1) DE19806438A1 (pt)
HR (1) HRP20000602A2 (pt)
HU (1) HUP0100957A3 (pt)
IL (1) IL137038A0 (pt)
NO (1) NO20004075L (pt)
PL (1) PL342311A1 (pt)
SK (1) SK11512000A3 (pt)
TR (1) TR200002376T2 (pt)
TW (1) TW579376B (pt)
WO (1) WO1999042453A1 (pt)
ZA (1) ZA991214B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924892A1 (de) * 1999-06-01 2000-12-07 Basf Ag Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten
US8217155B2 (en) 2007-07-31 2012-07-10 Gilead Colorado, Inc. Metabolites and derivatives of ambrisentan
CA2712777A1 (en) 2008-01-22 2009-07-30 Dow Agrosciences Llc 5-fluoro pyrimidine derivatives as fungicides
JP5580310B2 (ja) * 2008-08-01 2014-08-27 ダウ アグロサイエンシィズ エルエルシー 殺真菌剤としての５−フルオロシトシンの使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411225A1 (de) * 1994-03-31 1995-10-05 Basf Ag Verwendung von Carbonsäurederivaten als Arzneimittel
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
DE19614533A1 (de) * 1996-04-12 1997-10-16 Basf Ag Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung
DE19614534A1 (de) * 1996-04-12 1997-10-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
TR199901416T2 (xx) * 1996-12-18 1999-08-23 Basf Aktiengesellschaft Heterosiklik karbonikasit t�revleri.
DE19726146A1 (de) * 1997-06-19 1998-12-24 Basf Ag Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten
NZ504316A (en) * 1997-10-31 2002-12-20 Basf Ag Pyrimidine substituted carboxylic acid derivatives which have amido side-chains useful as endothelin receptor antagonists

Also Published As

Publication number Publication date
SK11512000A3 (sk) 2001-04-09
TW579376B (en) 2004-03-11
HRP20000602A2 (en) 2001-06-30
NO20004075D0 (no) 2000-08-15
HUP0100957A2 (hu) 2002-02-28
WO1999042453A1 (de) 1999-08-26
NO20004075L (no) 2000-08-15
CA2321182A1 (en) 1999-08-26
BG104577A (bg) 2001-03-30
AR014960A1 (es) 2001-04-11
JP2002503726A (ja) 2002-02-05
CN1291190A (zh) 2001-04-11
ZA991214B (en) 2000-08-16
EP1066268A1 (de) 2001-01-10
TR200002376T2 (tr) 2000-12-21
DE19806438A1 (de) 1999-08-19
IL137038A0 (en) 2001-06-14
KR20010086247A (ko) 2001-09-10
PL342311A1 (en) 2001-06-04
AU3027199A (en) 1999-09-06
HUP0100957A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
DE60322359D1 (de) Imidazopyridinderivate als kinaseinhibitoren
EA200602060A1 (ru) Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
CO5690551A2 (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo
DE60043349D1 (de) Chinazolin-derivate und ihre verwendung als arzneimittel
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
BRPI0606455A (pt) compostos farmacêuticos
DK1261602T3 (da) Imidazol-2-carboxamidderivater som Raf-kinaseinhibitorer
HUP0203122A2 (hu) Fab I inhibitorok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200200942A1 (ru) Фармацевтические композиции, содержащие производные 3-аминоазетидина, новые производные и способ их получения
CO5590895A2 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos
DE60032482D1 (de) 5-cyano-2-aminopyrimidine derivate
BR0213792A (pt) Heteroaril aminas como inibidores de glicogênio sintase cinase 3beta (inibidores de gsk3)
BR0306150A (pt) Composto, uso de um composto, e, composição farmacêutica
DE68924681D1 (de) Heterocyclische Biphosphonsäurederivate.
TW200613297A (en) Pyrazole derivatives
ATE211740T1 (de) Substituierte indazolderivate
EA200501041A1 (ru) Замещенные производные 1-пиперидин-4-ил-4-пирролидин-3-илпиперазина и их применение в качестве антагонистов нейрокининов
BR0214539A (pt) Preventivos ou remédios para doença de alzheimer ou inibidores de fibrose por proteìna amilóide, contendo compostos heteroarìlicos que contêm nitrogênio
BR9907911A (pt) Derivado de ácido carboxìlico, uso do mesmo, combinação, e, preparação de droga para administração oral, parenteral e intra-parenteral
ATE270266T1 (de) Quadratsäurederivate als integrin-antagonisten
AR045950A1 (es) Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
NO20053302D0 (no) Imidazolderivater med affinitet for alfa 2-reseptoraktivitet.
NO20074673L (no) Fosfatsalter av 6-dimetylaminometyl-L-(3-metoksyfenyl)1,3,dihydroksycykloheksanforbindelser

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ABBOTT GMBH & CO. KG (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.